Abaris Biotech.Opportunities A CHF/ LU2210124454 /
| NAV2024-05-24 | Chg.-2.0800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 59.6500CHF | -3.37% | reinvestment | Equity Worldwide | Hauck & Aufhäuser ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 7.36 | -0.50 | -8.86 | 1.52 | -9.24 | 8.68 | -9.55 | 4.95 | -3.70 | -0.39 | -14.11 | -0.80 | -24.35% |
| 2022 | -24.37 | 3.22 | 2.84 | -15.97 | -17.23 | 5.97 | 11.62 | 2.86 | -6.25 | 0.78 | -10.31 | -1.23 | -43.14% |
| 2023 | 15.58 | -6.54 | -12.30 | 2.30 | 5.01 | -2.25 | 0.30 | -7.72 | -6.23 | -18.46 | 18.78 | 26.59 | +5.86% |
| 2024 | 1.46 | 41.08 | -3.70 | -13.05 | 0.61 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 41.97% | 42.86% | 38.39% | 41.85% | -% |
| Sharpe ratio | 1.37 | 3.52 | 0.44 | -0.44 | - |
| Best month | +41.08% | +41.08% | +41.08% | +41.08% | - |
| Worst month | -13.05% | -13.05% | -18.46% | -24.37% | - |
| Maximum loss | -20.67% | -20.67% | -37.60% | -70.15% | - |
| Outperformance | -11.31% | - | - | - | - |
All quotes in CHF
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Abaris Biotech.Opportunities A C... | reinvestment | 59.6500 | +20.53% | -37.35% | |
| Abaris Biotech.Opportunities A E... | reinvestment | 65.1500 | +23.27% | -30.77% | |
| Abaris Biotech.Opportunities A U... | reinvestment | 59.1800 | +18.93% | -38.17% |
Performance
| YTD | +20.58% | ||
|---|---|---|---|
| 6 Months | +58.98% | ||
| 1 Year | +20.53% | ||
| 3 Years | -37.35% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -45.39% | ||
| Year | |||
| 2023 | +5.86% | ||
| 2022 | -43.14% | ||
| 2021 | -24.35% | ||
